Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
China Daily Global Edition5h
Teva, Kerry Pharma sign strategic partnership to build 4PL New Model, offering better solutions for patients in GBA
The global pharmaceutical company Teva announced a strategic partnership with Kerry Pharma, a subsidiary of the Kerry ...
Drugmakers agree to participate in second round of price negotiations
The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.
KC law firms help secure $73.5M EpiPen settlement for wholesaler buyers
Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...
Teva call volume above normal and directionally bullish
Bullish option flow detected in Teva (TEVA) with 17,095 calls trading, 1.7x expected, and implied vol increasing over 1 point to 42.32%. 3/14 ...